These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 28577953)
1. The impact of preoperative elevated serum C-reactive protein on postoperative morbidity and mortality after anatomic resection for lung cancer. Lopez-Pastorini A; Riedel R; Koryllos A; Beckers F; Ludwig C; Stoelben E Lung Cancer; 2017 Jul; 109():68-73. PubMed ID: 28577953 [TBL] [Abstract][Full Text] [Related]
2. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications. Okami J; Higashiyama M; Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Miyaoka E; J Thorac Oncol; 2009 Oct; 4(10):1247-53. PubMed ID: 19609223 [TBL] [Abstract][Full Text] [Related]
3. C-reactive protein (CRP) as a prognostic factor for colorectal cancer after surgical resection of pulmonary metastases. Li C; Xu Q; Chen L; Luo C; Ying J; Liu J Bull Cancer; 2017 Mar; 104(3):232-236. PubMed ID: 28063672 [TBL] [Abstract][Full Text] [Related]
4. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601 [TBL] [Abstract][Full Text] [Related]
5. Pneumonectomy for bronchogenic carcinoma: analysis of factors predicting survival. Ramnath N; Demmy TL; Antun A; Natarajan N; Nwogu CE; Loewen GM; Reid ME Ann Thorac Surg; 2007 May; 83(5):1831-6. PubMed ID: 17462408 [TBL] [Abstract][Full Text] [Related]
6. Postoperative complications of lung resection after induction chemotherapy using Paclitaxel (and radiotherapy) for advanced non-small lung cancer. Torre W; Sierra A J Cardiovasc Surg (Torino); 2002 Aug; 43(4):539-44. PubMed ID: 12124570 [TBL] [Abstract][Full Text] [Related]
7. Preoperative serum fibrinogen level predicts postoperative pulmonary complications after lung cancer resection. Song SW; Lee HS; Kim MS; Lee JM; Kim JH; Nam BH; Zo JI Ann Thorac Surg; 2006 Jun; 81(6):1974-81. PubMed ID: 16731116 [TBL] [Abstract][Full Text] [Related]
8. Extended pneumonectomy with partial resection of the left atrium, without cardiopulmonary bypass, for lung cancer. Spaggiari L; D' Aiuto M; Veronesi G; Pelosi G; de Pas T; Catalano G; de Braud F Ann Thorac Surg; 2005 Jan; 79(1):234-40. PubMed ID: 15620949 [TBL] [Abstract][Full Text] [Related]
9. Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis. Kawasaki H; Nagai K; Yoshida J; Nishimura M; Nishiwaki Y J Surg Oncol; 2002 Sep; 81(1):33-7. PubMed ID: 12210025 [TBL] [Abstract][Full Text] [Related]
10. [Diagnosis and surgical treatment of double primary lung cancer]. Wang Y; Wang L; Zhang D Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):428-30. PubMed ID: 11810780 [TBL] [Abstract][Full Text] [Related]
11. Sleeve lobectomy as an alternative to pneumonectomy in patients with operable lung cancer. Kasprzyk M; Dyszkiewicz W; Piwkowski C; Brudlo M; Galecki B; Gabryel P; Gasiorowski L Neoplasma; 2013; 60(1):62-7. PubMed ID: 23067218 [TBL] [Abstract][Full Text] [Related]
12. Completion pneumonectomy: a multicentre international study on 165 patients. Cardillo G; Galetta D; van Schil P; Zuin A; Filosso P; Cerfolio RJ; Forcione AR; Carleo F Eur J Cardiothorac Surg; 2012 Sep; 42(3):405-9. PubMed ID: 22398467 [TBL] [Abstract][Full Text] [Related]
13. Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication? Takeda S; Funakoshi Y; Kadota Y; Koma M; Maeda H; Kawamura S; Matsubara Y Ann Thorac Surg; 2006 Jul; 82(1):232-6. PubMed ID: 16798220 [TBL] [Abstract][Full Text] [Related]
14. Elevated preoperative C-reactive protein predicts poor cancer specific survival in patients undergoing resection for non-small cell lung cancer. O'Dowd C; McRae LA; McMillan DC; Kirk A; Milroy R J Thorac Oncol; 2010 Jul; 5(7):988-92. PubMed ID: 20453690 [TBL] [Abstract][Full Text] [Related]
16. [Surgery in non-small cell lung cancer of the superior sulcus: results of a combined preoperative and postoperative irradiation regime]. Pfannschmidt J; Muley T; Hoffmann H; Dienemann H Zentralbl Chir; 2004 Aug; 129(4):270-5. PubMed ID: 15354247 [TBL] [Abstract][Full Text] [Related]
17. Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer. Jones JM; McGonigle NC; McAnespie M; Cran GW; Graham AN Lung Cancer; 2006 Jul; 53(1):97-101. PubMed ID: 16698114 [TBL] [Abstract][Full Text] [Related]
18. Analyzing Risk Factors for Morbidity and Mortality after Lung Resection for Lung Cancer Using the NSQIP Database. Jean RA; DeLuzio MR; Kraev AI; Wang G; Boffa DJ; Detterbeck FC; Wang Z; Kim AW J Am Coll Surg; 2016 Jun; 222(6):992-1000.e1. PubMed ID: 27118714 [TBL] [Abstract][Full Text] [Related]
19. Lung cancer surgery: the first 60 days. A population-based study. Rostad H; Strand TE; Naalsund A; Talleraas O; Norstein J Eur J Cardiothorac Surg; 2006 May; 29(5):824-8. PubMed ID: 16520052 [TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of C-reactive protein in patients with stage I non-small cell lung cancer]. Shen L; Li ZM; Lu S Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):442-6. PubMed ID: 21875485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]